<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03200145</url>
  </required_header>
  <id_info>
    <org_study_id>FSIE1704</org_study_id>
    <secondary_id>CEEAH - 3786</secondary_id>
    <nct_id>NCT03200145</nct_id>
  </id_info>
  <brief_title>Person Centered Nursing Homes: Impact Assessment Of Centered Person Care In Nursing Homes</brief_title>
  <acronym>RECENPE</acronym>
  <official_title>Residències Centrades en Les Persones (RECENPE): avaluació de l'Impacte d'un Model d'ACP en residències Per Persones Grans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacio Salut i Envelliment UAB</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>SUMAR empresa d'acció social de Catalunya</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fundacio Salut i Envelliment UAB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cohort Observational Study. The study will assess differences in quality of life, well-being&#xD;
      and mood between persons living in a nursing home following usual care and persons living in&#xD;
      nursing homes following a centered person care model.&#xD;
&#xD;
      Initially, the follow up will last 6 months, with the possibility to be extended.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">June 27, 2017</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Thriving in nursing homes</measure>
    <time_frame>0, 6 months</time_frame>
    <description>Thriving in nursing homes will be assessed with the Thriving of Older People Assessment Scale (TOPAS).&#xD;
Investigators will assess the change between groups.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>0, 6 months</time_frame>
    <description>Quality of life will be assessed with the Euroqol 5D-5L. Investigators will assess the change between groups.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Well-being</measure>
    <time_frame>0, 6 months</time_frame>
    <description>Well-being will be assessed by the WHO (Five) Well Being Index (1998 version). Investigators will assess the change between groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depressive symptoms</measure>
    <time_frame>0, 6 months</time_frame>
    <description>Cognitive impairment affects the assessment of depressive symptoms. For this reason, according to their stage using the Reisberg Global Deterioration Scale, investigators will assess the presence or absence of depressive symptoms with two tools&#xD;
stage 0 to 4: investigators will consider that a person has depressive symptoms with a score of 6 or more using the 15 items Yesavage Geriatric Depression Scale,&#xD;
stage 5 to 7: investigators will consider that a person has depressive symptoms with a score of 11 or more using the Cornell Depression Scale.&#xD;
Investigators will assess the change in the prevalence of depressive symptoms between groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neuropsychiatric inventory</measure>
    <time_frame>0,6 months</time_frame>
    <description>Neuropsychiatric symptoms will be assessed with the Brief Neuropsychiatric inventory(NPI-Q). Investigators will assess the change between groups.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Health Services for the Aged</condition>
  <condition>Quality of Life</condition>
  <condition>Mood</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>The control group is made by persons living in nursing homes under usual care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ACP intervention</intervention_name>
    <description>The intervention group made by persons living in nursing homes using a person centered attention model relying on two dimensions:&#xD;
- Attention to the person based on:&#xD;
Knowledge of the person in several dimensions (biological, psychological, social, etc), interests and preferences.&#xD;
Respect and acknowledge of the person.&#xD;
Promotion of the autonomy.&#xD;
Personalized treatment, with tailored attention and integrative cures&#xD;
Protection of physical well-being, preventing damages and risks and promoting healthy habits.&#xD;
Promotion of independence on daily activities.&#xD;
Protection of privacy and personal matters&#xD;
- Positive environment based on:&#xD;
Physical space, including accessibility, comfort, homely environment, with stimulating spaces for physical activity, social relationships and significant activities for the persons.&#xD;
Social relationships, with proximity and collaboration with families.&#xD;
Friendly organization, with empathetic professionals empowering users.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Persons of any age with or without cognitive impairment living indefinitely in a nursing&#xD;
        home&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Persons living in nursing homes&#xD;
&#xD;
          -  Consent from the person (or legal representative, if the person is not able)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Terminal illness&#xD;
&#xD;
          -  Living temporary in a nursing home&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xavier Rojano Luque, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundació Salut i Envelliment UAB</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xavier Rojano Luque, MD</last_name>
    <phone>93 433 50 53</phone>
    <email>xavier.rojano@uab.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Antoni Salvà Casanovas, MD</last_name>
    <email>antoni.salva@uab.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Residència &quot;Casa del Avis&quot;</name>
      <address>
        <city>Sant Sadurní d'Anoia</city>
        <state>Barcelona</state>
        <zip>08770</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Aida Batet</last_name>
      <phone>+34 93 891 14 66</phone>
      <email>abatet@sumaracciosocial.cat</email>
    </contact>
    <contact_backup>
      <last_name>Neus Montserrat</last_name>
      <email>nmontserrat@sumaracciosocial.cat</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Residència i Centre de dia Sant Hilari</name>
      <address>
        <city>Sant Hilari Sacalm</city>
        <state>Girona</state>
        <zip>17403</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Gemma Puig</last_name>
      <phone>+34 972872800</phone>
      <email>gpuig@sumaracciosocial.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <study_first_submitted>June 20, 2017</study_first_submitted>
  <study_first_submitted_qc>June 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 27, 2017</study_first_posted>
  <last_update_submitted>June 26, 2017</last_update_submitted>
  <last_update_submitted_qc>June 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

